Diabetic foot ulcers and their recurrence

David G Armstrong, Andrew J.M. Boulton, Sicco A. Bus

Research output: Contribution to journalReview article

220 Citations (Scopus)

Abstract

Lower-extremity complications of diabetes such as foot ulcers constitute a substantial burden for people with diabetes. Once healed, foot ulcers frequently recur. This fact, coupled with demographic trends, requires a collective refocusing on prevention and a reallocation of resources from simply healing active ulcers to maximizing ulcer-free days for all patients with a history of diabetic foot ulceration. Aggressive therapy during active disease combined with a focus on improving care during remission can lead to more ulcer-free days, fewer inpatient and outpatient visits, and an improved quality of life.

Original languageEnglish (US)
Pages (from-to)2367-2375
Number of pages9
JournalNew England Journal of Medicine
Volume376
Issue number24
DOIs
StatePublished - Jun 15 2017

Fingerprint

Diabetic Foot
Foot Ulcer
Ulcer
Recurrence
Diabetes Complications
Inpatients
Lower Extremity
Outpatients
Quality of Life
Demography
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Diabetic foot ulcers and their recurrence. / Armstrong, David G; Boulton, Andrew J.M.; Bus, Sicco A.

In: New England Journal of Medicine, Vol. 376, No. 24, 15.06.2017, p. 2367-2375.

Research output: Contribution to journalReview article

Armstrong, David G ; Boulton, Andrew J.M. ; Bus, Sicco A. / Diabetic foot ulcers and their recurrence. In: New England Journal of Medicine. 2017 ; Vol. 376, No. 24. pp. 2367-2375.
@article{cae22ffe3a0d40ebb2e839662911282c,
title = "Diabetic foot ulcers and their recurrence",
abstract = "Lower-extremity complications of diabetes such as foot ulcers constitute a substantial burden for people with diabetes. Once healed, foot ulcers frequently recur. This fact, coupled with demographic trends, requires a collective refocusing on prevention and a reallocation of resources from simply healing active ulcers to maximizing ulcer-free days for all patients with a history of diabetic foot ulceration. Aggressive therapy during active disease combined with a focus on improving care during remission can lead to more ulcer-free days, fewer inpatient and outpatient visits, and an improved quality of life.",
author = "Armstrong, {David G} and Boulton, {Andrew J.M.} and Bus, {Sicco A.}",
year = "2017",
month = "6",
day = "15",
doi = "10.1056/NEJMra1615439",
language = "English (US)",
volume = "376",
pages = "2367--2375",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "24",

}

TY - JOUR

T1 - Diabetic foot ulcers and their recurrence

AU - Armstrong, David G

AU - Boulton, Andrew J.M.

AU - Bus, Sicco A.

PY - 2017/6/15

Y1 - 2017/6/15

N2 - Lower-extremity complications of diabetes such as foot ulcers constitute a substantial burden for people with diabetes. Once healed, foot ulcers frequently recur. This fact, coupled with demographic trends, requires a collective refocusing on prevention and a reallocation of resources from simply healing active ulcers to maximizing ulcer-free days for all patients with a history of diabetic foot ulceration. Aggressive therapy during active disease combined with a focus on improving care during remission can lead to more ulcer-free days, fewer inpatient and outpatient visits, and an improved quality of life.

AB - Lower-extremity complications of diabetes such as foot ulcers constitute a substantial burden for people with diabetes. Once healed, foot ulcers frequently recur. This fact, coupled with demographic trends, requires a collective refocusing on prevention and a reallocation of resources from simply healing active ulcers to maximizing ulcer-free days for all patients with a history of diabetic foot ulceration. Aggressive therapy during active disease combined with a focus on improving care during remission can lead to more ulcer-free days, fewer inpatient and outpatient visits, and an improved quality of life.

UR - http://www.scopus.com/inward/record.url?scp=85020544184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020544184&partnerID=8YFLogxK

U2 - 10.1056/NEJMra1615439

DO - 10.1056/NEJMra1615439

M3 - Review article

VL - 376

SP - 2367

EP - 2375

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 24

ER -